Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4455489
Max Phase: Preclinical
Molecular Formula: C13H10N2O3
Molecular Weight: 242.23
Molecule Type: Unknown
Associated Items:
ID: ALA4455489
Max Phase: Preclinical
Molecular Formula: C13H10N2O3
Molecular Weight: 242.23
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(Nc1ccccc1)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C13H10N2O3/c16-13(14-11-4-2-1-3-5-11)10-6-8-12(9-7-10)15(17)18/h1-9H,(H,14,16)
Standard InChI Key: KCBREZOWOLOPLW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 242.23 | Molecular Weight (Monoisotopic): 242.0691 | AlogP: 2.85 | #Rotatable Bonds: 3 |
Polar Surface Area: 72.24 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.01 | CX LogD: 3.01 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.66 | Np Likeness Score: -1.70 |
1. Wicht KJ, Combrinck JM, Smith PJ, Hunter R, Egan TJ.. (2016) Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum., 59 (13): [PMID:27299916] [10.1021/acs.jmedchem.6b00719] |
Source(1):